Airdate: Wednesday, July 27, 2022 Season: 9 Episode: 29
Guests: Peter Ansell, Marian Navratil
In this episode of #ExpertAnswers, Dr. Peter Ansell from AbbVie and Dr. Marian Navratil from HTG answer questions from a webinar where they discuss the use of novel RNA-based gene expression profiling technologies for clinical and preclinical oncology research.
For more information or to watch the webinar, click here.
Associated Webinar: Integration of the HTG Transcriptome Panel into Preclinical and Clinical Programs to Drive Precision Medicine Research
Similar Podcasts
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Lorcan Sherry and Aditya Pratapa on Analyzing Multiplex Immunofluorescence Images
Dr. Lorcan Sherry and Dr. Aditya Pratapa answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.
#ExpertAnswers: Conor McCartin on Phage Display Technologies
Dr. Conor McCartin from ProteoGenix answers questions about the utilization of phage display in the development of human antibodies.